Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Midregional pro-adrenomedullin plasma concentrations are blunted in severe preeclampsia.

Matson BC, Corty RW, Karpinich NO, Murtha AP, Valdar W, Grotegut CA, Caron KM.

Placenta. 2014 Sep;35(9):780-3. doi: 10.1016/j.placenta.2014.07.003. Epub 2014 Jul 10.

2.

Cardiovascular biomarkers in preeclampsia at triage.

Wellmann S, Benzing J, Fleischlin S, Morgenthaler N, Fouzas S, Bührer CA, Szinnai G, Burkhardt T, Lapaire O.

Fetal Diagn Ther. 2014;36(3):202-7. doi: 10.1159/000361016. Epub 2014 May 17.

PMID:
24853905
3.

Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.

Funke-Kaiser A, Havulinna AS, Zeller T, Appelbaum S, Jousilahti P, Vartiainen E, Blankenberg S, Sydow K, Salomaa V.

Ann Med. 2014 May;46(3):155-62. doi: 10.3109/07853890.2013.874662. Epub 2014 Feb 10.

PMID:
24506434
4.

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

Adlbrecht C, Hülsmann M, Strunk G, Berger R, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Jakowitsch J, Maurer G, Lang IM, Pacher R.

Eur J Heart Fail. 2009 Apr;11(4):361-6. doi: 10.1093/eurjhf/hfp004. Epub 2009 Feb 3.

5.

Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM.

Chest. 2009 Sep;136(3):823-831. doi: 10.1378/chest.08-1981. Epub 2009 Apr 10.

6.

Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.

Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C, Jin H, Du J.

J Am Coll Cardiol. 2012 Jul 24;60(4):315-20. doi: 10.1016/j.jacc.2012.04.025.

7.

Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection.

van der Starre WE, Zunder SM, Vollaard AM, van Nieuwkoop C, Stalenhoef JE, Delfos NM, Van't Wout JW, Spelt IC, Blom JW, Leyten EM, Koster T, Ablij HC, van Dissel JT.

Clin Microbiol Infect. 2014 Oct;20(10):1048-54. doi: 10.1111/1469-0691.12645.

8.

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.

J Am Coll Cardiol. 2007 Apr 10;49(14):1525-32. Epub 2007 Mar 26.

9.

Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.

Gordo-Remartínez S, Calderón-Moreno M, Fernández-Herranz J, Castuera-Gil A, Gallego-Alonso-Colmenares M, Puertas-López C, Nuevo-González JA, Sánchez-Sendín D, García-Gámiz M, Sevillano-Fernández JA, Álvarez-Sala LA, Andueza-Lillo JA, de Miguel-Yanes JM.

PLoS One. 2015 Jun 1;10(6):e0125212. doi: 10.1371/journal.pone.0125212. eCollection 2015.

10.

Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.

Cavallazzi R, El-Kersh K, Abu-Atherah E, Singh S, Loke YK, Wiemken T, Ramirez J.

Respir Med. 2014 Nov;108(11):1569-80. Review.

11.

Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.

Truong QA, Siegel E, Karakas M, Januzzi JL Jr, Bamberg F, Mahabadi AA, Dasdemir S, Brady TJ, Bergmann A, Kunde J, Nagurney JT, Hoffmann U, Koenig W.

Clin Chem. 2010 Apr;56(4):651-60. doi: 10.1373/clinchem.2009.138586. Epub 2010 Feb 25.

12.

Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.

Seifert-Held T, Pekar T, Gattringer T, Simmet NE, Scharnagl H, Bocksrucker C, Lampl C, Storch MK, Stojakovic T, Fazekas F.

PLoS One. 2013 Jul 22;8(7):e68768. doi: 10.1371/journal.pone.0068768. Print 2013.

13.

Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.

Xue Y, Taub P, Iqbal N, Fard A, Clopton P, Maisel A.

Eur J Heart Fail. 2013 Dec;15(12):1343-9. doi: 10.1093/eurjhf/hft116. Epub 2013 Jul 25.

14.

The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.

Holmager P, Schou M, Egstrup M, Gustafsson I, Goetze JP, Gustafsson F, Klausen TW, Faber J, Kistorp C.

J Card Fail. 2015 Mar;21(3):250-7. doi: 10.1016/j.cardfail.2014.12.007. Epub 2014 Dec 18.

PMID:
25528198
15.

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng LL, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Hartmann O, Morgenthaler NG, Anker SD.

J Am Coll Cardiol. 2011 Aug 30;58(10):1057-67. doi: 10.1016/j.jacc.2011.06.006.

16.

Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.

Bello S, Lasierra AB, Mincholé E, Fandos S, Ruiz MA, Vera E, de Pablo F, Ferrer M, Menendez R, Torres A.

Eur Respir J. 2012 May;39(5):1144-55. doi: 10.1183/09031936.00080411. Epub 2011 Nov 10.

17.

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.

Suberviola B, Castellanos-Ortega A, Llorca J, Ortiz F, Iglesias D, Prieto B.

Swiss Med Wkly. 2012 Mar 19;142:w13542. doi: 10.4414/smw.2012.13542.

18.

Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.

Funke-Kaiser A, Mann K, Colquhoun D, Zeller T, Hunt D, Simes J, Sullivan D, Sydow K, West M, White H, Blankenberg S, Tonkin AM; LIPID Study Investigators.

Int J Cardiol. 2014 Mar 15;172(2):411-8. doi: 10.1016/j.ijcard.2014.01.064. Epub 2014 Jan 24.

PMID:
24508492
19.
20.

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.

Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B.

Crit Care. 2005;9(6):R816-24. Epub 2005 Nov 15.

Supplemental Content

Support Center